NationalCovaxin Safe And Highly Effective In Children Between 2-18 Years Of Age, Shows StudyBY Outlook Web Desk
NationalCovaxin Booster Enhances Antibody Response Against COVID-19 Variants Including Omicron: StudyBY Outlook Web Desk
miscellaneousGovt's Decision On Covid Vaccination For Children 'Unscientific': Senior AIIMS EpidemiologistBY Outlook Web Desk
NationalFather-Daughter Duo Who Risked Life For Vaccine Trial Begs For Jabs For KinBY Jeevan Prakash Sharma
Making A DifferenceFDA Has Rejected Covaxin’s Emergency Use In America; Here’s WhyBY Outlook Web Bureau
NationalCovaxin Only For 18-44 Age Group Who Are Eligible For Second Dose: Delhi GovtBY Outlook Web Bureau
NationalAIIMS Delhi To Start Screening Children For Clinical Trials Of Covaxin From TodayBY Outlook Web Bureau
NationalCovid Explained: How Phase 2 And 3 Trials For Covaxin On Kids Will Be Conducted?BY Outlook Web Bureau
NationalExperts Recommend Bharat Biotech’s Covaxin For Phase 2/3 Trials On 2-18-Year-OldsBY Outlook Web Bureau
NationalCovaxin Is 78% Effective Against Mild To Severe Covid-19 Infections: Bharat BiotechBY Outlook Web Bureau
NationalHow Safe Is It To Have Sex After You Take Covid Vaccine? Experts Advise CautionBY Jeevan Prakash Sharma
NationalBhopal: Volunteer Dies 10 Days After Taking Bharat Biotech's Covaxin, Spurs ControversyBY Outlook Web Bureau
NationalWith 25,800 Volunteers, Bharat Biotech Completes Enrollment For Covaxin Phase-3 TrialsBY Outlook Web Bureau
NationalHaryana Health Minister Anil Vij Volunteers For Covid Vaccine, Gets Trial Dose Of CovaxinBY PTI
.jpg?auto=format%2Ccompress&fit=max&format=webp&w=300&dpr=1.0)
